Contribution of the familial and genetic factors on monocyte chemoattractant protein-1 variation in healthy human pedigrees

Cytokine

Volumn 32, Issue 2, 2005, Pages 117-123

  Pantsulaia, I ^a,b   Trofimov, S ^a   Kobyliansky, E ^a   Livshits, G ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b INSTITUTE OF PHYSICS   (Georgia)

Author keywords

Circulating levels; Heritability; Monocyte chemoattractant protein 1; Osteoprotegerin; Receptor activator NF kB ligand

Indexed keywords

COLONY STIMULATING FACTOR 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; BONE METABOLISM; BONE REMODELING; CAUCASIAN; CONFERENCE PAPER; CORRELATION ANALYSIS; COVARIANCE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; FEMALE; HEREDITY; HUMAN; MALE; NORMAL HUMAN; PEDIGREE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPOUSE;

ADULT; AGED; BONE AND BONES; BONE REMODELING; CARRIER PROTEINS; CHEMOKINE CCL2; ENVIRONMENT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; INTERLEUKIN-6; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OSTEOPROTEGERIN; PEDIGREE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27644531542     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2005.08.006     Document Type: Conference Paper

References (45)

1. M. Baggiolini, B. Dewald, and B. Moser Human chemokines: an update Annu Rev Immunol 15 1997 675 705
2. B.J. Rollins Chemokines Blood 90 1997 909 928
3. A.D. Luster Chemokines-chemotactic cytokines that mediate inflammation N Engl J Med 338 1998 436 445
4. L. Gu, S.C. Tseng, and B.J. Rollins Monocyte chemoattractant protein-1 Chem Immunol 72 1999 7 29
5. S. Kitamoto, and K. Egashira Gene therapy targeting monocyte chemoattractant protein-1 for vascular disease J Atheroscler Thromb 9 2002 261 265
6. C. Szalai, J. Duba, K. Prohaszka, A. Kalina, T. Szabo, and B. Nagy Involvement of polymorphism in the chemokine system in the susceptibility of coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1-2518 G/G genotype CAD patients Atherosclerosis 158 2001 233 239
7. C. Szalai, G.T. Kozma, A. Nagy, A. Bojszko, D. Krikovszky, and T. Szabo Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity J Allergy Clin Immunol 108 2001 375 381
8. T. Kaburaki, Y. Fujino, H. Kawashima, G. Merino, J. Numaga, and J. Chen Plasma and whole blood chemokine levels in patients with Behcet's disease Graefes Arch Clin Exp Ophthalmol 241 2003 353 358
9. J.A. de Lemos, D.A. Morrow, M.S. Sabatine, S.A. Murphy, C.M. Gibson, and E.M. Antman Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes Circulation 107 2003 690 695
10. S. Tanaka, I. Nakamura, J.I. Inoue, H. Oda, and K. Nakamura Signal transduction pathways regulating osteoclast differentiation and function J Bone Miner Metab 21 2003 123 133
11. X. Yu, Y. Huang, P. Collin-Osdoby, and P. Osdoby CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts J Bone Miner Res 12 2004 2065 2077
12. D.T. Graves, Y. Jiang, and A.J. Valente The expression of monocyte chemoattractant protein-1 and other chemokines by osteoblasts Front Biosci 4 1999 d571 d580
13. S. Hanazawa, A. Akeshita, S. Amano, T. Semba, T. Nirazuka, and H. Katoh Tumor necrosis factor-alpha induces expression of monocyte chemoattractant JE via fos and jun genes in clonal osteoblastic MC3T3-E1 cells J Biol Chem 268 1993 9526 9532
14. T.S. Kwan, M. Padrines, S. Théoleyre, D. Heymann, and Y. Fortun IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology Cytokine Growth Factor Rev 15 2004 49 60
15. J. Zwerina, S. Hayer, M. Tohidast-Akrad, H. Bergmeister, K. Redlich, and U. Feige Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction Arthritis Rheum 50 2004 277 290
16. I. Pantsulaia, S. Trofimov, E. Kobyliansky, and G. Livshits Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population Cytokine 19 2002 138 146
17. P.M. de Maat, M.P. de Maat, E.M. Bladbjerg, J.B. Hjelmborg, L. Bathum, and J. Jespersen Genetic Influence on Inflammation Variables in the Elderly Arterioscler Thromb Vasc Biol 11 2004 2168 2173
18. G. Livshits, I. Pantsulaia, S. Trofimov, and E. Kobyliansky Genetic influences on the circulating cytokines involved in osteoclastogenesis J Med Genet 41 6 2004 e76
19. H. Inadera, K. Egashira, M. Takemoto, Y. Ouchi, and K. Matsushima Increase in circulating levels of monocyte chemoattractant protein-1 with aging J Interferon Cytokine Res 10 1999 1179 1182
20. M.L. Cho, J.Y. Kim, H.J. Ko, Y.H. Kim, W.U. Kim, and C.S. Cho The MCP-1 promoter -2518 polymorphism in Behcet's disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients Autoimmunity 37 2004 77 80
21. C. Fenoglio, D. Galimberti, C. Lovati, I. Guidi, A. Gatti, and S. Fogliarino MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels Neurobiol Aging 9 2004 1169 1173
22. G. Livshits, D. Karasik, and E. Kobyliansky Complex segregation analysis of the radiographic phalanges bone mineral density and their age-related changes J Bone Miner Res 17 2002 152 161
23. S. Trofimov, I. Pantsulaia, E. Kobyliansky, and G. Livshits Circulating levels of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin/ macrophage-colony stimulating factor in a presumably healthy human population Eur J Endocrinol 150 2004 305 311
24. Malkin I, Ginsburg E. Program package for Mendelian analysis of pedigree data (MAN, Version 6. Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel Aviv University. Technical Report; 2003.
25. M. Boehnke, P.P. Moll, B.A. Kottke, and W.H. Weidman Partitioning the variability of fasting plasma glucose levels in pedigrees. Genetic and environmental factors Am J Epidemiol 125 1987 679 689
26. D.S. Falconer, and T.F. Mackay Introduction to quantitative genetics 4th ed. 1996 Longman London p. 145-284
27. K. Lange, D. Weeks, and M. Boehnke Program for pedigree analysis: MENDEL, FISHER and dGENE Genet Epidemiol 5 1988 471 472
28. L. Piemonti, G. Calori, A. Mercalli, G. Lattuada, P. Monti, and M.P. Garancini Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality Diabetes Care 26 2003 2883 2889
29. P. Jilma-Stohlawetz, M. Homoncik, C. Drucker, C. Marsik, A. Rot, and W.R. Mayr Fy phenotype and gender determine plasma levels of monocyte chemotactic protein Transfusion 41 2001 378 381
30. A. Arici, L.M. Senturk, E. Seli, M.O. Bahtiyar, and G. Kim Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by estrogen and progesterone Biol Reprod 61 1999 85 90
31. B. Zietz, C. Buchler, H. Herfarth, U. Muller-Ladner, D. Spiegel, and J. Scholmerich Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A-G promoter polymorphism Diabetes Obesity Metab 6 2004 1 9
32. B. Rovin, L. Lu, and R. Saxena A novel polymorphism in the MCP-1 Gene regulatory region that influences MCP-1 Expression Biochem Biophys Res Commun 259 1999 344 346
33. H. Hsu, D.L. Lacey, C.R. Dunstan, I. Solovyev, A. Colombero, and E. Timms Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand Proc Natl Acad Sci USA 96 1999 3540 3545
34. H. Yasuda, N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, and M. Goto A novel molecular mechanism modulating osteoclast differentiation and function Bone 25 1999 109 113
35. R. Westendorp, J. Langermans, T. Huzinga, A. Elouali, C. Verweij, and D. Boomsma Genetic influence on cytokine production and fatal meningococcal disease Lancet 349 1997 170 173
36. J.C. Souto, L. Almasy, J. Blangero, W. Stone, M. Borrell, and T. Urrutia Genetic regulation of plasma levels of vitamin K-dependent proteins involved in hematostatis: results from the GAIT Project. Genetic Analysis of Idiopathic Thrombophilia Thromb Haemost 85 2001 88 92
37. C.Y. Vossen, S.J. Hasstedt, F.R. Rosendaal, P.W. Callas, K.A. Bauer, and G.J. Broze Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family J Thromb Haemost 2 2004 242 247
38. D. Hunter, M. De Lange, H. Snieder, A.J. MacGregor, R. Swaminathan, and R.V. Thakker Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation J Bone Miner Res 2 2001 371 378
39. G. Livshits Genetic epidemiology of skeletal system aging in apparently healthy human population Mech Ageing Dev 126 2005 269 279
40. D.J. Grainger, K. Heathcote, M. Chiano, H. Snieder, P.R. Kemp, and J.C. Metcalfe Genetic control of the circulating concentration of transforming growth factor type beta1 Hum Mol Genet 8 1999 93 97
41. H.L. Kim, D.S. Lee, S.H. Yang, J.H. Chung, S. Kim, and J.S. Lee The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE Am J Kidney Dis 40 2002 1146 1152
42. M.F. Gonzalez-Escribano, B. Torres, F. Aguilar, R. Rodriguez, A. Garcia, and A. Valenzuela MCP-1 promoter polymorphism in Spanish patients with rheumatoid arthritis Hum Immunol 64 2003 741 744
43. S. Karrer, A.K. Bosserhoff, P. Weiderer, O. Distler, M. Landthaler, and R.M. Szeimies The -2518 promoter polymorphism in the MCP-1 gene is associated with systemic sclerosis J Invest Dermatol 124 2005 92 98
44. P.G. McGlinchey, M.S. Spence, C.C. Patterson, A.R. Allen, G. Murphy, and C. Belton Lack of association between the -2518G/A polymorphism of the MCP-1 gene and ischemic heart disease: a family-based investigation Tissue Antigens 64 2004 199 203
45. T.C. Yao, K.C. Wu, H.T. Chung, C.K. Shaw, M.L. Kuo, and C.J. Wu MCP-1 gene regulatory region polymorphism in Chinese children with mild, moderate and near-fatal asthma Allergy 59 2004 436 441